craft-sa-dev Home  

PMC:1584416 / 27033-27945 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T4969 0-3 NN denotes TTD
T4971 3-4 HYPH denotes -
T4970 4-12 JJ denotes specific
T4973 13-22 JJ denotes cutaneous
T4974 23-26 CC denotes and
T4975 27-34 JJ denotes anaemic
T4972 35-43 NNS denotes features
T4977 43-45 , denotes ,
T4978 45-47 IN denotes on
T4979 48-51 DT denotes the
T4981 52-57 JJ denotes other
T4980 58-62 NN denotes hand
T4982 62-64 , denotes ,
T4983 64-67 VBP denotes are
T4976 68-75 VBN denotes thought
T4984 76-78 TO denotes to
T4985 79-85 VB denotes result
T4986 86-90 IN denotes from
T4987 91-92 DT denotes a
T4989 93-101 JJ denotes specific
T4988 102-106 NN denotes kind
T4990 107-109 IN denotes of
T4991 110-125 JJ denotes transcriptional
T4992 126-139 NN denotes insufficiency
T4993 140-146 VBN denotes caused
T4994 147-149 IN denotes by
T4995 150-159 NN denotes depletion
T4996 160-162 IN denotes of
T4997 163-171 JJ denotes unstable
T4998 172-177 NN denotes TFIIH
T4999 178-184 IN denotes during
T5000 185-188 DT denotes the
T5002 189-197 JJ denotes terminal
T5001 198-213 NN denotes differentiation
T5003 214-216 IN denotes of
T5004 217-221 NN denotes skin
T5006 221-223 , denotes ,
T5007 223-227 NN denotes hair
T5009 227-228 HYPH denotes -
T5008 228-233 NN denotes shaft
T5010 233-235 , denotes ,
T5011 235-238 CC denotes and
T5012 239-244 NN denotes blood
T5005 245-250 NNS denotes cells
T5013 251-252 -LRB- denotes [
T5015 252-254 CD denotes 16
T5016 254-255 , denotes ,
T5014 255-257 CD denotes 24
T5017 257-258 -RRB- denotes ]
T5018 258-259 . denotes .
T5019 259-504 sentence denotes In compound heterozygous mice, both homozygous lethal Xpd†XPCS and Xpd†XP alleles were able to alleviate XpdTTD-specific cutaneous and anaemic features and can thus be defined as dominant over the XpdTTD allele with respect to these phenotypes.
T5020 260-262 IN denotes In
T5022 263-271 NN denotes compound
T5024 272-284 JJ denotes heterozygous
T5023 285-289 NNS denotes mice
T5025 289-291 , denotes ,
T5026 291-295 DT denotes both
T5028 296-306 JJ denotes homozygous
T5029 307-313 JJ denotes lethal
T5030 314-322 NN denotes Xpd†XPCS
T5031 323-326 CC denotes and
T5032 327-333 NN denotes Xpd†XP
T5027 334-341 NNS denotes alleles
T5021 342-346 VBD denotes were
T5033 347-351 JJ denotes able
T5034 352-354 TO denotes to
T5035 355-364 VB denotes alleviate
T5036 365-371 NN denotes XpdTTD
T5038 371-372 HYPH denotes -
T5037 372-380 JJ denotes specific
T5040 381-390 JJ denotes cutaneous
T5041 391-394 CC denotes and
T5042 395-402 JJ denotes anaemic
T5039 403-411 NNS denotes features
T5043 412-415 CC denotes and
T5044 416-419 MD denotes can
T5046 420-424 RB denotes thus
T5047 425-427 VB denotes be
T5045 428-435 VBN denotes defined
T5048 436-438 IN denotes as
T5049 439-447 JJ denotes dominant
T5050 448-452 IN denotes over
T5051 453-456 DT denotes the
T5053 457-463 NN denotes XpdTTD
T5052 464-470 NN denotes allele
T5054 471-475 IN denotes with
T5055 476-483 NN denotes respect
T5056 484-486 IN denotes to
T5057 487-492 DT denotes these
T5058 493-503 NNS denotes phenotypes
T5059 503-504 . denotes .
T5060 504-721 sentence denotes We conclude that the defects leading to embryonic lethality and aberrant terminal differentiation of the skin, hair, and blood represent two qualitatively and/or quantitatively different transcriptional deficiencies.
T5061 505-507 PRP denotes We
T5062 508-516 VBP denotes conclude
T5063 517-521 IN denotes that
T5065 522-525 DT denotes the
T5066 526-533 NNS denotes defects
T5067 534-541 VBG denotes leading
T5068 542-544 IN denotes to
T5069 545-554 JJ denotes embryonic
T5070 555-564 NN denotes lethality
T5071 565-568 CC denotes and
T5072 569-577 JJ denotes aberrant
T5074 578-586 JJ denotes terminal
T5073 587-602 NN denotes differentiation
T5075 603-605 IN denotes of
T5076 606-609 DT denotes the
T5077 610-614 NN denotes skin
T5078 614-616 , denotes ,
T5079 616-620 NN denotes hair
T5080 620-622 , denotes ,
T5081 622-625 CC denotes and
T5082 626-631 NN denotes blood
T5064 632-641 VBP denotes represent
T5083 642-645 CD denotes two
T5085 646-659 RB denotes qualitatively
T5087 660-663 CC denotes and
T5088 663-664 HYPH denotes /
T5089 664-666 CC denotes or
T5090 667-681 RB denotes quantitatively
T5086 682-691 JJ denotes different
T5091 692-707 JJ denotes transcriptional
T5084 708-720 NNS denotes deficiencies
T5092 720-721 . denotes .
T5093 721-912 sentence denotes During early embryonic development, XpdTTD is dominant over the Xpd†XPCS and Xpd†XP alleles, whereas later in the ontogenesis of skin, hair-shaft, and blood cells, the situation is reversed.
T5094 722-728 IN denotes During
T5096 729-734 JJ denotes early
T5098 735-744 JJ denotes embryonic
T5097 745-756 NN denotes development
T5099 756-758 , denotes ,
T5100 758-764 NN denotes XpdTTD
T5095 765-767 VBZ denotes is
T5101 768-776 JJ denotes dominant
T5102 777-781 IN denotes over
T5103 782-785 DT denotes the
T5105 786-794 NN denotes Xpd†XPCS
T5106 795-798 CC denotes and
T5107 799-805 NN denotes Xpd†XP
T5104 806-813 NNS denotes alleles
T5108 813-815 , denotes ,
T5109 815-822 IN denotes whereas
T5111 823-828 RB denotes later
T5112 829-831 IN denotes in
T5113 832-835 DT denotes the
T5114 836-847 NN denotes ontogenesis
T5115 848-850 IN denotes of
T5116 851-855 NN denotes skin
T5117 855-857 , denotes ,
T5118 857-861 NN denotes hair
T5120 861-862 HYPH denotes -
T5119 862-867 NN denotes shaft
T5121 867-869 , denotes ,
T5122 869-872 CC denotes and
T5123 873-878 NN denotes blood
T5124 879-884 NNS denotes cells
T5125 884-886 , denotes ,
T5126 886-889 DT denotes the
T5127 890-899 NN denotes situation
T5128 900-902 VBZ denotes is
T5110 903-911 VBN denotes reversed
T5129 911-912 . denotes .
R3334 T4969 T4970 npadvmod TTD,specific
R3335 T4970 T4972 amod specific,features
R3336 T4971 T4970 punct -,specific
R3337 T4972 T4976 nsubjpass features,thought
R3338 T4973 T4972 amod cutaneous,features
R3339 T4974 T4973 cc and,cutaneous
R3340 T4975 T4973 conj anaemic,cutaneous
R3341 T4977 T4976 punct ", ",thought
R3342 T4978 T4976 prep on,thought
R3343 T4979 T4980 det the,hand
R3344 T4980 T4978 pobj hand,on
R3345 T4981 T4980 amod other,hand
R3346 T4982 T4976 punct ", ",thought
R3347 T4983 T4976 auxpass are,thought
R3348 T4984 T4985 aux to,result
R3349 T4985 T4976 xcomp result,thought
R3350 T4986 T4985 prep from,result
R3351 T4987 T4988 det a,kind
R3352 T4988 T4986 pobj kind,from
R3353 T4989 T4988 amod specific,kind
R3354 T4990 T4988 prep of,kind
R3355 T4991 T4992 amod transcriptional,insufficiency
R3356 T4992 T4990 pobj insufficiency,of
R3357 T4993 T4988 acl caused,kind
R3358 T4994 T4993 agent by,caused
R3359 T4995 T4994 pobj depletion,by
R3360 T4996 T4995 prep of,depletion
R3361 T4997 T4998 amod unstable,TFIIH
R3362 T4998 T4996 pobj TFIIH,of
R3363 T4999 T4995 prep during,depletion
R3364 T5000 T5001 det the,differentiation
R3365 T5001 T4999 pobj differentiation,during
R3366 T5002 T5001 amod terminal,differentiation
R3367 T5003 T5001 prep of,differentiation
R3368 T5004 T5005 nmod skin,cells
R3369 T5005 T5003 pobj cells,of
R3370 T5006 T5004 punct ", ",skin
R3371 T5007 T5008 compound hair,shaft
R3372 T5008 T5004 conj shaft,skin
R3373 T5009 T5008 punct -,shaft
R3374 T5010 T5008 punct ", ",shaft
R3375 T5011 T5008 cc and,shaft
R3376 T5012 T5008 conj blood,shaft
R3377 T5013 T5014 punct [,24
R3378 T5014 T4976 parataxis 24,thought
R3379 T5015 T5014 nummod 16,24
R3380 T5016 T5014 punct ",",24
R3381 T5017 T5014 punct ],24
R3382 T5018 T4976 punct .,thought
R3383 T5020 T5021 prep In,were
R3384 T5022 T5023 nmod compound,mice
R3385 T5023 T5020 pobj mice,In
R3386 T5024 T5023 amod heterozygous,mice
R3387 T5025 T5021 punct ", ",were
R3388 T5026 T5027 det both,alleles
R3389 T5027 T5021 nsubj alleles,were
R3390 T5028 T5027 amod homozygous,alleles
R3391 T5029 T5027 amod lethal,alleles
R3392 T5030 T5027 nmod Xpd†XPCS,alleles
R3393 T5031 T5030 cc and,Xpd†XPCS
R3394 T5032 T5030 conj Xpd†XP,Xpd†XPCS
R3395 T5033 T5021 acomp able,were
R3396 T5034 T5035 aux to,alleviate
R3397 T5035 T5033 xcomp alleviate,able
R3398 T5036 T5037 npadvmod XpdTTD,specific
R3399 T5037 T5039 amod specific,features
R3400 T5038 T5037 punct -,specific
R3401 T5039 T5035 dobj features,alleviate
R3402 T5040 T5039 amod cutaneous,features
R3403 T5041 T5040 cc and,cutaneous
R3404 T5042 T5040 conj anaemic,cutaneous
R3405 T5043 T5021 cc and,were
R3406 T5044 T5045 aux can,defined
R3407 T5045 T5021 conj defined,were
R3408 T5046 T5045 advmod thus,defined
R3409 T5047 T5045 auxpass be,defined
R3410 T5048 T5045 prep as,defined
R3411 T5049 T5048 amod dominant,as
R3412 T5050 T5045 prep over,defined
R3413 T5051 T5052 det the,allele
R3414 T5052 T5050 pobj allele,over
R3415 T5053 T5052 compound XpdTTD,allele
R3416 T5054 T5045 prep with,defined
R3417 T5055 T5054 pobj respect,with
R3418 T5056 T5055 prep to,respect
R3419 T5057 T5058 det these,phenotypes
R3420 T5058 T5056 pobj phenotypes,to
R3421 T5059 T5021 punct .,were
R3422 T5061 T5062 nsubj We,conclude
R3423 T5063 T5064 mark that,represent
R3424 T5064 T5062 ccomp represent,conclude
R3425 T5065 T5066 det the,defects
R3426 T5066 T5064 nsubj defects,represent
R3427 T5067 T5066 acl leading,defects
R3428 T5068 T5067 prep to,leading
R3429 T5069 T5070 amod embryonic,lethality
R3430 T5070 T5068 pobj lethality,to
R3431 T5071 T5070 cc and,lethality
R3432 T5072 T5073 amod aberrant,differentiation
R3433 T5073 T5070 conj differentiation,lethality
R3434 T5074 T5073 amod terminal,differentiation
R3435 T5075 T5073 prep of,differentiation
R3436 T5076 T5077 det the,skin
R3437 T5077 T5075 pobj skin,of
R3438 T5078 T5077 punct ", ",skin
R3439 T5079 T5077 conj hair,skin
R3440 T5080 T5079 punct ", ",hair
R3441 T5081 T5079 cc and,hair
R3442 T5082 T5079 conj blood,hair
R3443 T5083 T5084 nummod two,deficiencies
R3444 T5084 T5064 dobj deficiencies,represent
R3445 T5085 T5086 advmod qualitatively,different
R3446 T5086 T5084 amod different,deficiencies
R3447 T5087 T5085 cc and,qualitatively
R3448 T5088 T5087 punct /,and
R3449 T5089 T5087 cc or,and
R3450 T5090 T5085 conj quantitatively,qualitatively
R3451 T5091 T5084 amod transcriptional,deficiencies
R3452 T5092 T5062 punct .,conclude
R3453 T5094 T5095 prep During,is
R3454 T5096 T5097 amod early,development
R3455 T5097 T5094 pobj development,During
R3456 T5098 T5097 amod embryonic,development
R3457 T5099 T5095 punct ", ",is
R3458 T5100 T5095 nsubj XpdTTD,is
R3459 T5101 T5095 acomp dominant,is
R3460 T5102 T5101 prep over,dominant
R3461 T5103 T5104 det the,alleles
R3462 T5104 T5102 pobj alleles,over
R3463 T5105 T5104 nmod Xpd†XPCS,alleles
R3464 T5106 T5105 cc and,Xpd†XPCS
R3465 T5107 T5105 conj Xpd†XP,Xpd†XPCS
R3466 T5108 T5095 punct ", ",is
R3467 T5109 T5110 mark whereas,reversed
R3468 T5110 T5095 advcl reversed,is
R3469 T5111 T5110 advmod later,reversed
R3470 T5112 T5111 prep in,later
R3471 T5113 T5114 det the,ontogenesis
R3472 T5114 T5112 pobj ontogenesis,in
R3473 T5115 T5114 prep of,ontogenesis
R3474 T5116 T5115 pobj skin,of
R3475 T5117 T5116 punct ", ",skin
R3476 T5118 T5119 compound hair,shaft
R3477 T5119 T5116 conj shaft,skin
R3478 T5120 T5119 punct -,shaft
R3479 T5121 T5119 punct ", ",shaft
R3480 T5122 T5119 cc and,shaft
R3481 T5123 T5124 compound blood,cells
R3482 T5124 T5119 conj cells,shaft
R3483 T5125 T5110 punct ", ",reversed
R3484 T5126 T5127 det the,situation
R3485 T5127 T5110 nsubjpass situation,reversed
R3486 T5128 T5110 auxpass is,reversed
R3487 T5129 T5095 punct .,is